Location: Boston, MA, United States

We are building a premier life sciences investment firm within J.P. Morgan. Your role is critical to building our Healthcare Life Sciences Private Capital business and the Healthcare Growth Fund. The Healthcare Growth Fund targets growth-stage companies across life sciences, including de-risked clinically-validated biotechnology and commercial-stage pharma services, medical devices, tools and diagnostics.

Job Summary:

As an Associate within the Life Sciences Private Capital team, you will leverage your strong analytical background to help in identifying and evaluating targets. A passion for healthcare and an understanding of business and market dynamics in the medical device, biopharma, and life sciences tools and services sectors will be crucial to your role. This role offers the opportunity to be a key participant in the investment process from opportunity identification through due diligence, transaction structuring, documentation, and deal closing.

Job Responsibilities:

• Financial analysis and modeling of investment opportunities
• Detailed product and market diligence, forecasting and sensitivity analysis
• Maintain deal flow tracking and management system
• Develop investment theses and perspectives on investment themes/areas
• Financial, business and scientific diligence from both secondary and primary sources
• Information aggregation, synthesis and dissemination to team
• Collate all transaction memoranda and help present materials to investment committee 

 

Required capabilities and qualifications:

• Undergraduate degree from a top-tier university
• 3+ years of industry experience ideally in life sciences investment banking or consulting
• Excellent writing, communication, presentation, and analytical skills
• Advanced Excel and Powerpoint skills
• Team oriented, highly coachable and exceptional work ethic
• Demonstrable passion for investing and healthcare 
• Highly entrepreneurial and self-motivated

 

The ideal candidate will have significant experience with complex modeling, product and market assessment and evaluation.